Cannabinoid receptor type 1 antagonist inhibits progression of obesity‐associated nonalcoholic steatohepatitis in a mouse model by remodulating immune system disturbances-Reference-Cited by-同舟云学术

Cannabinoid receptor type 1 antagonist inhibits progression of obesity‐associated nonalcoholic steatohepatitis in a mouse model by remodulating immune system disturbances

Published:2020-08-15 Issue:4 Volume:8 Page:544-558
ISSN:2050-4527
Container-title:Immunity, Inflammation and Disease
language:en
Short-container-title:Immun Inflamm Dis

Author:

Chen Chin‐Chang¹²,Chang Zi‐Yu¹³,Tsai Fuu‐Jen⁴⁵⁶,Chen Shih‐Yin⁴⁵^ORCID

Affiliation:

1. Department of Traditional Chinese Medicine Chang Gung Memorial Hospital Keelung Taiwan, ROC

2. Department of Anatomy, School of Medicine China Medical University Taichung Taiwan, ROC

3. Institute of Traditional Medicine, School of Medicine National Yang‐Ming University Taipei Taiwan, ROC

4. School of Chinese Medicine China Medical University Taichung Taiwan, ROC

5. Department of Medical Research, Genetics Center China Medical University Hospital Taichung Taiwan, ROC

6. Department of Medical Genetics China Medical University Hospital Taichung Taiwan, ROC

Funder

Clinical Trial Center, China Medical University Hospital

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/iid3.338

Reference39 articles.

1. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

2. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis

3. The Role of Cytokines in Non-Alcoholic Fatty Liver Disease

4. Non Alcoholic Fatty Liver: Epidemiology and Natural History

5. Innate Immunity and Inflammation in NAFLD/NASH

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The molecular signature of the peripheral cannabinoid receptor 1 antagonist AM6545 in adipose, liver and muscle tissue;Toxicology and Applied Pharmacology;2024-10

2. Inhibiting the CB1 receptor in CIH-induced animal model alleviates colon injury;Applied Microbiology and Biotechnology;2024-06-18

3. The Role of Cannabinoid-1 Receptor Ligands in the Ovalbumin-Induced Mouse Model of Allergic Asthma: Is It Related to Transient Receptor Potential Vanilloid-1 Channels?;Cannabis and Cannabinoid Research;2024-04-24

4. Molecular Targets for Cannabinoids in Natural Killer Cells: Do They Modulate the Antitumor Activity?;Receptors;2024-03-25

5. Molecular networks underlying cannabinoid signaling in skeletal muscle plasticity;Journal of Cellular Physiology;2022-07-21